Acesso livre
Acesso livre

Clínica Médica

Revisão | Tratamento da dor pós-operatória em vias melhoradas de recuperação (“enhanced recovery pathways”).

28 Jan, 2022 | 16:01h

Postoperative Pain Management in Enhanced Recovery Pathways – Journal of Pain Research

Revisão narrativa e abordagem prática | Efeitos colaterais de curto prazo relacionados a glicocorticoides e reações adversas.

28 Jan, 2022 | 15:56h

Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach – Swiss Medical Weekly

Estudo de coorte | Entre sobreviventes de tratamento em UTI para COVID-19, 75% ainda relatam sintomas físicos, mentais e cognitivos depois de 1 ano.

28 Jan, 2022 | 15:45h

Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19 – JAMA

Comentários:

75% of COVID ICU survivors have physical symptoms 1 year on – CIDRAP

Majority of COVID-19 survivors experience health problems one-year post ICU admission – News Medical

Casos de miocardite relatados após vacinação contra COVID-19 baseada em mRNA nos EUA de dezembro de 2020 até agosto de 2021.

28 Jan, 2022 | 15:43h

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021 – JAMA

Comentário: COVID 19: Risk of Myocarditis Highest Following Second Vaccine Dose Among Adolescent and Young Adult Males – MedicalResearch.com

Conteúdos relacionados:

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

Enquanto Pfizer e BioNTech iniciam um estudo clínico de vacina baseada na variante Ômicron, não se tem clareza quanto ao tempo para autorização.

28 Jan, 2022 | 15:41h

As Pfizer and BioNTech begin clinical trial of Omicron-based vaccine, timeline to authorization is unclear – STAT

Ver também:

Pfizer begins testing omicron-matched COVID shots in adults – Associated Press

Pfizer and BioNTech start trials of new Omicron-specific jab – BBC

Pfizer and BioNTech begin testing an omicron-specific COVID-19 vaccine – NPR

Opinião | Prevenção da transmissão do SARS-CoV-2 em ambientes de cuidados em saúde no contexto da variante Ômicron.

28 Jan, 2022 | 15:38h

Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant – JAMA

 

Comentário no Twitter

 

[Preprint] Alta prevalência de distúrbios do olfato 18 meses depois do contágio pela COVID-19.

28 Jan, 2022 | 15:36h

High prevalence of olfactory disorders 18 months after contracting COVID-19 – medRxiv

Comentários:

Half of first-wave Covid cases may have lasting harm to sense of smell – The Guardian

Prevalence of olfactory dysfunction 18 months after SARS-CoV-2 infection – News Medical

Diretriz de recomendação USPSTF | Ainda não há evidências suficientes para recomendar o rastreamento de fibrilação atrial.

28 Jan, 2022 | 15:35h

Final Recommendation Statement: Screening for Atrial Fibrillation – U.S. Preventive Services Task Force

Ver também: Screening for Atrial Fibrillation: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Entrevista com o autor: USPSTF Recommendation: Screening for Atrial Fibrillation – JAMA

Editoriais:

Screening for Atrial Fibrillation—More Data Still Needed – JAMA

Screening for Atrial Fibrillation—New Devices, Same Challenges – JAMA Internal Medicine

Updated USPSTF Guidelines for Screening for Atrial Fibrillation: Same as It Ever Was? – JAMA Cardiology

Screening for Atrial Fibrillation—Refining the Target – JAMA Network Open

Página do paciente JAMA: Screening for Atrial Fibrillation

Comentário: USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking – TCTMD

Diretrizes sobre o tratamento da dissecção de aorta tipo B.

28 Jan, 2022 | 15:33h

The Society of Thoracic Surgeons/American Association for Thoracic Surgery Clinical Practice Guidelines on the Management of Type B Aortic Dissection – Annals of Thoracic Surgery

Comunicado de imprensa: New practice guideline addresses diagnosis, treatment of type B aortic dissection – The Society of Thoracic Surgeons

Estudo randomizado | Terapia de observação eletrônica direta é não inferior à terapia de observação pessoal para garantir a adesão ao tratamento da tuberculose.

28 Jan, 2022 | 15:30h

In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial – JAMA Network Open

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.